AstraZeneca and Daiichi Sankyo have moved swiftly to file for FDA approval of a second indication for their TROP2-directed antibody-drug conjugate datopotamab deruxtecan (Dato-DXd), this time for ...
Megan O’Sullivan is a writer based in Brooklyn. On her desk is a vintage brass table lamp, a porcelain Royal Copenhagen cup ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback